Agrawal Yash N; Fernandez-Martinez Aranzazu; Gil-Gil Miguel; Zielinski Christoph; Ruiz-Borrego Manuel; Ciruelos Eva Maria; Munoz Montserrat; Margeli Mireia; Bermejo Begona; Anton Antonio; Kahán Zsuzsanna; Csöszi Tibor; Alonso-Romero Jose Luis; Garcia-Saenz Jose Angel; Sanchez-Rovira Pedro; Alvarez Elena; Chacon Jose Ignacio; Gonzalez-Santiago Santiago; Rodriguez Cesar A; Servitja Sonia; Pfefferle Adam D; Herranz Jesus; Liu Yuan; Carey Lisa A; Romero-Camarero Isabel; Caballero Rosalia; Guerrero-Zotano Angel; Perou Charles M; Martin Miguel:
Transcriptomic Predictors of Survival for Palbociclib + Endocrine Therapy Versus Capecitabine in Aromatase Inhibitor-Resistant Breast Cancer From the GEICAM/2013-02 PEARL Trial.
JCO PRECISION ONCOLOGY, 9.
ISSN 2473-4284
(2025)
Pascual Javier; Gil-Gil Miguel; Proszek Paula; Zielinski Christoph; Reay Alistair; Ruiz-Borrego Manuel; Cutts Rosalind; Ciruelos Gil Eva M; Feber Andrew; Muñoz-Mateu Montserrat; Swift Claire; Bermejo Begoña; Herranz Jesus; Kahán Zsuzsanna; Csöszi Tibor:
Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients.
CLINICAL CANCER RESEARCH, 29 (20).
pp. 4166-4177.
ISSN 1078-0432
(2023)
Prager Gerald W.; Taieb Julien; Fakih Marwan; Ciardiello Fortunato; Van Cutsem Eric; Elez Elena; Cruz Felipe M.; Wyrwicz Lucjan; Stroyakovskiy Daniil; Pápai Zsuzsanna; Poureau Pierre-Guillaume; Liposits Gabor; Cremolini Chiara; Bondarenko Igor; Modest Dominik P.; Benhadji Karim A.; Kollaborációs szervezet: SUNLIGHT Investigators; Árkosy Péter; Bodoky György; Csejtei András; Csöszi Tibor; Horváth Zsolt; Nagy Zoltán; Oláh Judit Magdolna; Sipőcz István:
Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer.
NEW ENGLAND JOURNAL OF MEDICINE, 388 (18).
pp. 1657-1667.
ISSN 0028-4793
(2023)
Kahán Zsuzsanna; Gil-Gil Miguel; Ruiz-Borrego Manuel; Carrasco Eva; Ciruelos Eva; Muñoz Montserrat; Bermejo Begoña; Margeli Mireia; Antón Antonio; Casas Maribel; Csöszi Tibor; Murillo Laura; Morales Serafín; Calvo Lourdes; Láng István:
Health-related quality of life with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor–positive metastatic breast cancer: Patient-reported outcomes in the PEARL study.
EUROPEAN JOURNAL OF CANCER, 156.
pp. 70-82.
ISSN 0959-8049
(2021)
Martin M.; Zielinski C.; Ruiz-Borrego M.; Carrasco E.; Turner N.; Ciruelos E. M.; Muñoz M.; Bermejo B.; Margeli M.; Anton A.; Kahán Zsuzsanna; Csöszi Tibor; Casas M. I.; Murillo L.; Morales S.:
Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial—PEARL.
ANNALS OF ONCOLOGY, 32 (4).
pp. 488-499.
ISSN 0923-7534
(2021)